2022
DOI: 10.1007/s10527-022-10158-7
|View full text |Cite
|
Sign up to set email alerts
|

An Optoelectronic Spectral Sensor for Monitoring the Elimination of Uremic Markers with Low and Middle Molecular Weight during Hemodialysis Therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 23 publications
0
1
0
Order By: Relevance
“…The interpretation of the second peak is not so obvious. Our proposition about the AGE products is based on preliminary experiments with the fluorescent spectra of the various chromatographic fractions of hemodialysate and AGE products observed during HD [66][67][68][69]; however, additional comprehensive research is needed to fully support this suggestion. The clinical significance of the second and the third peaks in the chromatograms is yet to be investigated; the second peak is of special interest because AGE products are responsible for cardiovascular complications and other pathological conditions in PD patients [70][71][72].…”
Section: Discussionmentioning
confidence: 99%
“…The interpretation of the second peak is not so obvious. Our proposition about the AGE products is based on preliminary experiments with the fluorescent spectra of the various chromatographic fractions of hemodialysate and AGE products observed during HD [66][67][68][69]; however, additional comprehensive research is needed to fully support this suggestion. The clinical significance of the second and the third peaks in the chromatograms is yet to be investigated; the second peak is of special interest because AGE products are responsible for cardiovascular complications and other pathological conditions in PD patients [70][71][72].…”
Section: Discussionmentioning
confidence: 99%